Education
About Us
Working with TipRanks
Follow Us
Matthew O'Brien Profile - Piper Sandler Analyst
522 Followers
Matthew O'Brien Piper Sandler
Wall Street Analyst
Success Rate
193 out of 493 ratings made a profit
Average Return
-5.40%
Average return per rating
Time Frame
Compare to
Copying Matthew O'Brien's trades since 2012 and holding each position for 1 Year would result in 39.15% of your transactions generating a profit, with an average return of -5.4% per rating.
Stock Rating Distribution
82.19% Buy
17.55% Hold
0.26% Sell
Distribution of Matthew O'Brien's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Matthew O'Brien
Matthew O'Brien's Stock Coverage
Mako Surgical
May 08, 2012
Hold
Downgraded
―
2Ratings
―
0.00%
Xtant Medical Holdings
Aug 14, 2014
Buy
Reiterated
―
2Ratings
―
0.00%
CR Bard
Sep 16, 2014
Hold
Reiterated
―
1Ratings
―
0.00%
LDR Holding
Jun 07, 2016
Hold
Downgraded
―
7Ratings
―
0.00%
CMS Bancorp
Oct 31, 2016
Buy
Reiterated
―
1Ratings
―
0.00%
Novadaq
Jan 10, 2017
Buy
Reiterated
―
11Ratings
―
0.00%
Zeltiq Aesthetics
Feb 13, 2017
Hold
Downgraded
―
15Ratings
―
0.00%
NxStage Medical
May 09, 2017
Buy
Reiterated
―
10Ratings
―
0.00%
Resmed
Aug 02, 2017
Hold
Reiterated
$70.00
(-71.39% Downside)
8Ratings
―
0.00%
DENTSPLY SIRONA
Aug 09, 2017
Buy
Reiterated
$69.00
(564.10% Upside)
9Ratings
―
0.00%
List of latest recommendations made by Matthew O'Brien. Click to expand and see Matthew O'Brien's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Matthew O'Brien activity FAQ
What is the performance of Matthew O'Brien's recommendations?
The percentage of profitable recommendations made by Matthew O'Brien is 39%, and the average return per transaction is -5.40%.
What was Matthew O'Brien's most profitable rating?
Matthew O'Brien’s most profitable ratings was a buy on PRCT stock on Nov 06, 2023 - Nov 06, 2024. The return on the trade was +199.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here